FOXM1 and ovarian serous adenocarcinoma: More data will be needed to elucidate the involvement of FOXM1 in serous ovarian cancer development and progression, but these findings are potentially important with regard to therapeutic strategies, since potent inhibitors of FOXM1 exist, which are known to have tumor suppressing capacity in other malignancies [74].